An Integrative Evaluation Method for the Biological Safety of Down and Feather Materials.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
21 Mar 2019
Historique:
received: 28 01 2019
revised: 15 03 2019
accepted: 18 03 2019
entrez: 24 3 2019
pubmed: 25 3 2019
medline: 17 7 2019
Statut: epublish

Résumé

Down and feather materials have been commonly used and promoted as natural stuffing for warm clothing and bedding. These materials tend to become more allergenic as they become contaminated with microorganisms, in addition to being subjected to several kinds of chemical treatments. The biological or chemical contaminants in these materials pose a major risk to human health, to consumers and manufacturers alike. Here, we report the development of an integrative evaluation method for down and feather materials to assess bacterial contamination and in vivo toxicity. To assess bacterial contamination, we quantified 16S ribosomal RNA, performed culture tests, and established a conversion formula. To determine in vivo toxicity, we performed a zebrafish embryo toxicity testing (ZFET). Washing the material appropriately decreases the actual number of bacteria in the down and feather samples; in addition, after washing, 16S rRNA sequencing revealed that the bacterial compositions were similar to those in rinse water. The ZFET results showed that even materials with low bacterial contamination showed high toxicity or high teratogenicity, probably because of the presence of unknown chemical additives. We established an integrative evaluation method for down and feather safety, based on bacterial contamination with in vivo toxicity testing.

Sections du résumé

BACKGROUND BACKGROUND
Down and feather materials have been commonly used and promoted as natural stuffing for warm clothing and bedding. These materials tend to become more allergenic as they become contaminated with microorganisms, in addition to being subjected to several kinds of chemical treatments. The biological or chemical contaminants in these materials pose a major risk to human health, to consumers and manufacturers alike. Here, we report the development of an integrative evaluation method for down and feather materials to assess bacterial contamination and in vivo toxicity.
METHODS METHODS
To assess bacterial contamination, we quantified 16S ribosomal RNA, performed culture tests, and established a conversion formula. To determine in vivo toxicity, we performed a zebrafish embryo toxicity testing (ZFET).
RESULTS RESULTS
Washing the material appropriately decreases the actual number of bacteria in the down and feather samples; in addition, after washing, 16S rRNA sequencing revealed that the bacterial compositions were similar to those in rinse water. The ZFET results showed that even materials with low bacterial contamination showed high toxicity or high teratogenicity, probably because of the presence of unknown chemical additives.
CONCLUSIONS CONCLUSIONS
We established an integrative evaluation method for down and feather safety, based on bacterial contamination with in vivo toxicity testing.

Identifiants

pubmed: 30901881
pii: ijms20061434
doi: 10.3390/ijms20061434
pmc: PMC6471580
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Appl Microbiol. 2004;96(3):560-8
pubmed: 14962136
Toxicol Sci. 2005 Jul;86(1):6-19
pubmed: 15703261
Blood. 2011 Jan 27;117(4):e49-56
pubmed: 21084707
PLoS One. 2010 Nov 30;5(11):e15101
pubmed: 21152087
Eur J Oral Sci. 2011 Dec;119(6):447-54
pubmed: 22112030
Water Res. 2013 Jul 1;47(11):3854-64
pubmed: 23651515
Regul Toxicol Pharmacol. 2014 Aug;69(3):496-511
pubmed: 24874798
Fish Shellfish Immunol. 2015 Aug;45(2):286-92
pubmed: 25956719
J Nanosci Nanotechnol. 2015 Mar;15(3):2140-7
pubmed: 26413632
Allergy. 1998 Feb;53(2):159-64
pubmed: 9534914

Auteurs

Toshikatsu Kawada (T)

Kawada Feather Co., Ltd., Nagoya, Aichi 453-0064, Japan. toshi@kawada.net.

Junya Kuroyanagi (J)

UMOU Science Lab, Mastusaka, Mie 515-0074, Japan. kuro@umou.or.jp.

Fumiyoshi Okazaki (F)

Department of Life Sciences, Graduate School of Bioresources, Mie University, Tsu, Mie 514-8507, Japan. okazaki@bio.mie-u.ac.jp.
Department of Bioinformatics, Mie University Advanced Science Research Promotion Center, Tsu, Mie 514-8507, Japan. okazaki@bio.mie-u.ac.jp.
Mie University Zebrafish Drug Screening Center, Tsu, Mie 514-8507, Japan. okazaki@bio.mie-u.ac.jp.

Mizuki Taniguchi (M)

Department of Life Sciences, Graduate School of Bioresources, Mie University, Tsu, Mie 514-8507, Japan. 515557@m.mie-u.ac.jp.

Hiroko Nakayama (H)

Mie University Zebrafish Drug Screening Center, Tsu, Mie 514-8507, Japan. 27293301@m.mie-u.ac.jp.
Graduate School of Regional Innovation Studies, Mie University, Tsu, Mie 514-8507, Japan. 27293301@m.mie-u.ac.jp.

Narumi Suda (N)

UMOU Science Lab, Mastusaka, Mie 515-0074, Japan. suda@umou.or.jp.

Souta Abiko (S)

Boken Quality Evaluation Institute, Minato-Ku, Osaka 552-0021, Japan. abikoa@boken.or.jp.

Satoshi Kaneco (S)

Department of Chemistry for Materials, Graduate School of Engineering, Mie University, Tsu, Mie 514-8507, Japan. kaneco@chem.mie-u.ac.jp.

Norihiro Nishimura (N)

Mie University Zebrafish Drug Screening Center, Tsu, Mie 514-8507, Japan. nishimura.norihiro@mie-u.ac.jp.
Graduate School of Regional Innovation Studies, Mie University, Tsu, Mie 514-8507, Japan. nishimura.norihiro@mie-u.ac.jp.

Yasuhito Shimada (Y)

Department of Bioinformatics, Mie University Advanced Science Research Promotion Center, Tsu, Mie 514-8507, Japan. shimada.yasuhito@mie-u.ac.jp.
Mie University Zebrafish Drug Screening Center, Tsu, Mie 514-8507, Japan. shimada.yasuhito@mie-u.ac.jp.
Department of Integrative Pharmacology, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan. shimada.yasuhito@mie-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH